INTRODUCTION
Regulation of ethanolamine metabolism in mammalian cells is not well understood. Two major metabolic fates of ethanolamine are phosphatidylethanolamine (PtdEtn) biosynthesis and formation of the phosphatidylinositol-glycan linkage present in certain proteins [1] . PtdEtn is produced in animal cells by three different biosynthetic pathways: (i) from ethanolamine via CDP-ethanolamine [2] , (ii) from the decarboxylation of phosphatidylserine (PtdSer) [3] and (iii) from a base-exchange reaction between ethanolamine and a pre-existing molecule of PtdSer or phosphatidylcholine [4, 5] . The relative contribution of these three biosynthetic pathways is not precisely known but might be different among different cell types. For example, in cultured baby hamster kidney fibroblasts and Chinese hamster ovary (CHO) cells the majority of PtdEtn is derived from PtdSer decarboxylation, even when the cells are supplemented with ethanolamine [6] [7] [8] . However, in rat liver, the CDP-ethanolamine pathway appears to be quantitatively important [9] . In liver, the rate of synthesis of PtdEtn from CDP-ethanolamine has been calculated to be 0.3 ,umol/min per liver [10] whereas the rate ofsynthesis ofPtdEtn from PtdSer decarboxylation has been estimated to be 10-fold lower (0.03 ,tmol/min per liver [11] ). It is generally accepted that the base-exchange pathway is not a quantitatively major pathway for PtdEtn synthesis [12, 13] .
Ethanolamine that is-used for PtdEtn synthesis originates either from a base-exchange reaction between serine and PtdEtn [4, 5] or as unbound ethanolamine from the circulation in intact animals. Media used for cell culture usually contain a very low concentration of free ethanolamine (most often in the range of 10% of that in serum), although certain cultured cells require ethanolamine as a growth factor [14, 15] . The [16, 17] , in fetal bovine serum the concentration is 23.4 ,uM [17] whereas in hamsters the plasma concentration of ethanolamine is much higher (0.9 mM) [18] . However, these levels can fluctuate depending on the metabolic status of the animal. For example, immediately after partial hepatectomy in rats the ethanolamine level of serum increases from 29 to 50 ,uM [19] .
Extracellular ethanolamine is readily imported into cells (e.g. rabbit retina [20] , hamster heart [18] , Y79 retinoblastoma cells [21] and cultured bovine aortic endothelial cells [17] ) by both high-and low-affinity transport systems. Addition of ethanolamine to the medium of cultured cells increases the sizes of the intracellular pools of ethanolamine and phosphoethanolamine [6, 16, 17] , and over the long-term increases the content of PtdEtn in the cells [17, 22, 23] .
In [24] , and in hypoxic myocytes PtdEtn is a substrate for phospholipase A [25] . Moreover, two baseexchange activities have been identified in CHO cells [7, 26, 27] .
Abbreviations used: CHO, Chinese hamster ovary; DMEM, Dulbecco's modified Eagle's medium; MEM, minimum essential medium; PtdEtn, phosphatidylethanolamine; PtdSer, phosphatidylserine.
One of these enzymes, PtdSer synthase I, catalyses a baseexchange reaction with PtdSer, PtdEtn and phosphatidylcholine, whereas the other, PtdSer synthase II, apparently uses PtdSer and PtdEtn, but not phosphatidylcholine. To our knowledge, the existence of a mammalian phospholipase C activity that hydrolyses PtdEtn has not been reported.
In the present study we have investigated the recycling of the ethanolamine moiety of PtdEtn. We have compared the effect of cell growth and supplementation of the culture medium of CHOkl cells with exogenous ethanolamine on the metabolism of PtdEtn derived from its two biosynthetic origins: PtdSer decarboxylation and ethanolamine. We propose the existence of a PtdEtn-ethanolamine cycle in which ethanolamine is continually released from CDP-ethanolamine-derived PtdEtn, and recycled back into PtdEtn, in both confluent and dividing cells. In cells prelabelled with [3H]ethanolamine, and subsequently supplemented with ethanolamine, the radioactive ethanolamine released from PtdEtn enters, and is diluted by, an intracellular pool of ethanolamine of low specific radioactivity, and consequently the radioactivity in PtdEtn gradually declines. In contrast, the PtdEtn-ethanolamine cycle is essentially dormant for PtdSerderived PtdEtn in confluent cells, although the cycle is stimulated when the CHO-kl cells are actively dividing. [3-3H] serine, CHO-kl cells were washed twice with serine-free MEM, then incubated with 3 ml/dish serum-free serine-free MEM containing 5 ,uCi/ml [3-3H] serine for 1 h. For confluent cells, the medium was removed and replaced with 5 ml of DMEM containing 1 mM serine, with or without 1 mM ethanolamine. For non-confluent cells, after the 1 h pulse, the medium was replaced with Ham's F12 medium supplemented with 10% fetal bovine serum, with or without 1 mM ethanolamine.
MATERIALS AND METHODS
For all labelling experiments, media were collected after defined chase periods and cells were harvested by scraping into PBS. Lipids were extracted by the addition of 3 vol. of chloroform/ methanol (2:1, v/v). Unlabelled carrier phospholipids were added to each sample and individual phospholipids isolated by TLC in the solvent system chloroform/methanol/acetic acid/ formic acid/water (70:30:12:4:2, by vol.). Ethanolamine, phosphoethanolamine and CDP-ethanolamine were isolated by TLC in the solvent system ammonia/methanol/aq. 0.6 % NaCl (1:10:10, by vol).
Other methods Cellular protein content was determined by the method of Lowry et al. [29] with BSA as a standard. Lipid phosphorus was analysed by the method of Rouser and Fleischer [30] . Ethanolamine is a potential degradation product of PtdEtn that could be generated by the action of either phospholipase C or phospholipase D [31] (Figures 2a and 2b) .
RESULTS

Specific radioactivity of ethanolamine-derived PtdEtn decreases
The major radiolabelled metabolite generated from the degradation of [3H]PtdEtn was ethanolamine. In studies in other cell types, such as hepatocytes [16] and might be due to either contamination with a small amount of radiolabelled glycerophosphoethanolamine (from which CDP-ethanolamine is poorly separated on the TLC system used) or might reflect a reversal of the reaction catalysed by CDP-ethanolaminediacylglycerol ethanolaminephosphotransferase. In the absence of exogenous unlabelled ethanolamine, the total radioactivity in CDP-ethanolamine, phosphoethanolamine and ethanolamine combined in non-confluent cells was less than Figure  4 (a), the specific radioactivity of PtdSer declined during the chase period with a concomitant increase in specific radioactivity of PtdEtn (Figure 4b ). Unlike [3H]ethanolamine-derived PtdEtn, however, for which the specific radioactivity decreased on addition of ethanolamine (Figure la) , the specific radioactivity Parallel experiments were performed with actively dividing CHO-kl cells that had been labelled with [3H]serine. In the absence of exogenous ethanolamine, the specific radioactivities of PtdSer (Figure 6a ) and PtdEtn ( Figure 6b ) were similar to those in confluent cells (Figures 4a and 4b) . The addition of ethanolamine to the chase medium neither altered the specific radioactivity of PtdSer (Figure 6a ) nor affected the rate of loss of radioactivity from PtdSer (Figures 7a and 7b) . However, the specific radioactivity of PtdEtn was lower in the presence of ethanolamine than in its absence (Figure 6b ). This difference in specific radioactivity of PtdEtn in cells cultured in the presence and absence of ethanolamine was not the result of a decreased rate of production of PtdEtn from PtdSer because the loss of radioactivity from PtdSer (d.p.m/dish) was not significantly influenced by ethanolamine (Figures 7a and 7b) . Moreover, in non-confluent cells incubated without ethanolamine the radioactivity in PtdSer declined as the radioactivity in PtdEtn increased (Figure 7a ), and essentially no [3H]ethanolamine was detected (Figure 7c ). In contrast, in non-confluent cells incubated in the presence of ethanolamine the radioactivity in PtdSer declined. However, after 6 h the radioactivity in PtdEtn no longer increased (Figure 7b ), but the radioactivity in ethanolamine increased (Figure 7c ), suggesting that PtdSer was converted into PtdEtn and that some PtdEtn had been degraded to ethanolamine. The results of these experiments with non-confluent cells are different from those in confluent cells ( Figure 5 ), as in the latter no significant release of ethanolamine was detected either in the presence or absence of exogenous unlabelled ethanolamine.
DISCUSSION
Our data suggest that an active ethanolamine cycle exists in CHO-kl cells, in which ethanolamine is continually released from, and re-incorporated into, PtdEtn as shown in the model depicted in Figure 8 . According to this model, ethanolamine is released from PtdEtn and re-incorporated back into PtdEtn, 37 'C. The pulse medium was removed and cells were incubated in chase medium containing 10% fetal bovine serum and 1 mM serine with (closed symbols) or without (open symbols) 1 mM unlabelled ethanolamine for an additional 2-23 h. At the indicated times, medium and cells from one dish were harvested and lipids extracted. Parallel dishes were used to determine the phosphorus content of PtdSer and PtdEtn for calculation of specific radioactivities of (a) PtdSer and (b) PtdEtn. Data are means+ S.D. of three independent experiments. In some instances error bars are too small to be visible.
most likely via CDP-ethanolamine, but from our data we cannot exclude a re-incorporation of some ethanolamine into PtdEtn via a base-exchange reaction. 23 h. In contrast, when ethanolamine (1 mM) was added to the culture medium, the radioactivity in PtdEtn gradually declined. A similar observation was made by Yorek et al. [21] with cultured bovine aortic endothelial cells supplemented with 25 ,uM ethanolamine. Our data suggest that the decline in radioactivity in PtdEtn is not due to stimulation of PtdEtn breakdown induced by ethanolamine. Rather, in the presence of exogenous ethanolamine, [3H]ethanolamine is released from PtdEtn into a cellular pool of ethanolamine, the specific activity of which is greatly decreased by the high concentration (1 mM) of exogenous unlabelled ethanolamine (Figure 8a) . Consequently, the specific radioactivity of ethanolamine used for PtdEtn synthesis is lower than that in cells incubated without 1 mM ethanolamine, and the specific radioactivity of the resulting PtdEtn gradually declines. In contrast, in the absence ofexogenous unlabelled ethanolamine, the released [3H]ethanolamine is not significantly diluted, is rapidly recycled back into PtdEtn, and does not accumulate in cells or medium. The recycling of ethanolamine and PtdEtn occurs to a similar extent in both confluent and actively dividing cells. This explanation for the decline in specific radioactivity of PtdEtn is supported by the observations that (i) the amount of [3H]ethanolamine released corresponds quantitatively to the decrease in radioactivity in PtdEtn, and (ii) the addition of ethanolamine does not stimulate the breakdown of 32P-labelled PtdEtn.
For PtdSer-derived PtdEtn we propose that a similar recycling of the ethanolamine moiety occurs (Figure 8b ) only in cells that Figure  8 (b), is not active with PtdSer-derived PtdEtn. In contrast, in non-confluent cells PtdSer-derived PtdEtn is continually catabolized, ethanolamine is released, and PtdEtn is subsequently resynthesized using an intracellular pool of ethanolamine of specific radioactivity that has been diluted by exogenously supplied unlabelled ethanolamine. Our data suggest that PtdEtn derived from the CDP-ethanolamine pathway and from PtdSer decarboxylation is differently utilized in the ethanolamine cycle. The compartmentalization of phospholipids into specific metabolic pools on the basis of their biosynthetic origin has been previously observed. For example, only a small newly synthesized pool of PtdSer is thought to be utilized for decarboxylation to PtdEtn [11, 32, 33] . Similarly, PtdEtn newly made from ethanolamine, rather than the bulk of cellular PtdEtn, is preferred for methylation to phosphatidylcholine in rat hepatocytes [34] . Furthermore, the methylation of PtdEtn derived from two alternative sources (ethanolamine and PtdSer) is differently affected by the inhibitor 3-deaza-adenosine [35, 36] . Other studies have demonstrated that in rat hepatocytes ethanolamine-derived PtdEtn is not significantly remodelled by deacylation-reacylation [34] , whereas PtdEtn derived from PtdSer is actively deacylated and reacylated [37] . In addition, pools of phosphatidylcholine and PtdEtn derived from PtdSer decarboxylation, rather than from CDP-ethanolamine, are preferred for secretion into lipoproteins by rat hepatocytes [38] .
The reason why in confluent cells the ethanolamine cycle operates only for PtdEtn derived from CDP-ethanolamine, but not for PtdEtn derived from PtdSer, is not known. One possible explanation is that ethanolamine released from PtdSer-derived PtdEtn enters a pool different from that diluted by the exogenous ethanolamine. A similar compartmentalization of pools of aqueous precursors of phospholipids in rat glioma cells has been previously suggested [39] . However, this explanation does not appear to be likely because in non-confluent cells, ethanolamine released from PtdSer-derived PtdEtn is diluted by ethanolamine added to the culture medium. A more feasible explanation, and one that is consistent with our data, is that two different enzymes, which are differently regulated according to the growth status of the cells, are used for release of ethanolamine from the PtdEtn originating via the two different biosynthetic routes. One scenario might be that the ethanolamine-releasing enzyme that utilizes PtdSer-derived PtdEtn is only stimulated when the cells are actively dividing. On the other hand, the enzyme that liberates ethanolamine from ethanolamine-derived PtdEtn might be active in both confluent and non-confluent cells. Our data do not provide any information on which enzyme(s) is/are responsible for liberation of ethanolamine from PtdEtn. A likely candidate for the ethanolamine-releasing enzyme is a base-exchange enzyme, although ethanolamine might alternatively be released by the action of phospholipase C or D. However, the existence of two PtdSer synthases (base-exchange enzymes) has been implicated in CHO cells [26, 27] ; one, designated PtdSer synthase I, catalyses a base-exchange reaction with PtdSer, PtdEtn and phosphatidylcholine, whereas the other, PtdSer synthase II, uses PtdSer and PtdEtn, but not phosphatidylcholine. Our currently favoured explanation for the data is that one of the PtdSer synthases releases ethanolamine from PtdSer-derived PtdEtn, and is active only during active cell growth, whereas the other PtdSer synthase releases ethanolamine from PtdEtn made from CDP-ethanolamine, and is active in both confluent and nonconfluent cells. It would not be unreasonable that PtdSer synthase, which apparently operates in both a synthetic and a degradative capacity, would be stimulated during active cell growth. Confirmation ofthese speculations awaits further characterization of the two PtdSer synthases.
